BiotechTube
Home/Strykagen/David Maine
DM

David Maine

Chief Financial Officer

Strykagen

Therapeutic Areas

Rare Muscle DiseasesMuscular Dystrophy

Strykagen Pipeline

DrugIndicationPhase
Myomatrix Stabilization ProgramDuchenne Muscular Dystrophy (DMD)Preclinical
Diagnostics & BiomarkersMuscular Dystrophy (Diagnosis/Prognosis)Development

Leadership Team at Strykagen

DD
Dr. Dean J. Burkin
Founder, President and CEO
DR
Dr. Ryan Wuebbles
Chief Scientific Officer
View full Strykagen profile